Bertil Lindmark
Chief Tech/Sci/R&D Officer en VICORE PHARMA HOLDING AB .
Fortuna: 11 108 $ al 30/04/2024
Origen de la red de primer grado Bertil Lindmark.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
University of Lund
57
| College/University | Other Consumer Services | 57 |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden.
34
| Private Company | Investment Managers | 34 |
| Public Company | Biotechnology | 21 | |
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Pharmaceuticals: Major | 10 | |
Xgen Venture Sgr SpA
 Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy.
10
| Private Company | Investment Managers | 10 |
Cellevate AB
 Cellevate AB Miscellaneous Commercial ServicesCommercial Services Cellevate AB is a Swedish biotech company that specializes in developing advanced cell culture systems. The private company is based in Lund, Sweden. The company's patented manufacturing process creates highly porous and consistent networks of nanofibers. Cellevate was founded by Lars Gosta Montelius.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
| Public Company | Pharmaceuticals: Major | 6 | |
Aslan Pharmaceuticals (Shanghai) Co. Ltd.
2
| Subsidiary | 2 | |
Astrazeneca Japan Ltd.
 Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram.
1
| Subsidiary | Medical/Nursing Services | 1 |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.
1
| Subsidiary | Biotechnology | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Bertil Lindmark a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
Congenia Srl
 Congenia Srl Miscellaneous Commercial ServicesCommercial Services Congenia SRL operates as pharmaceutical company, is engaged in the development of novel therapeutics for diseases associated with mitochondrial stress-induced dysfunction. The company develops small molecule drugs that target the mitochondrial permeability transition pore, a protein channel with various macromolecular components that along with mitochondrial protein p66, appears to be associated with oxidative stress-induced cell death. The company was founded in 2004 by Saverio Minucci, Pier Giuseppe Pelicci, Marco Giorgio and Paolo Bernardi and is headquartered in Milan, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer | |
| COLOPLAST A/S | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| GN STORE NORD A/S | Telecommunications Equipment | Director/Board Member Chief Executive Officer | |
| ACTIVE BIOTECH AB | Biotechnology | Chief Executive Officer General Counsel | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Lundbeck Foundation
 Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chief Executive Officer Director/Board Member | |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Pharmacia AB /Hillerod Unit/
 Pharmacia AB /Hillerod Unit/ Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin Graduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree | |
| University of Uppsala | College/University | Graduate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
| Umea Universitet | College/University | Doctorate Degree Doctorate Degree | |
| University of Gothenburg | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Genextra SpA
 Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Investment Managers | Chief Executive Officer Director/Board Member Private Equity Investor | |
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Medical Specialties | Director/Board Member Director/Board Member | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| LIDDS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Biotechnology | Chief Executive Officer Director/Board Member Chairman | |
ALK-Abelló BV
 ALK-Abelló BV Pharmaceuticals: MajorHealth Technology Part of ALK-Abello A/S, ALK-Abelló BV is a Dutch company that has been providing various allergy treatments since 1923. The private company has developed an adrenaline auto-injector for the emergency treatment of acute severe allergic reactions. ALK-Abelló BV offers job opportunities for individuals who are passionate about making a difference in the field of allergies. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member Founder Chief Executive Officer | |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ACUCORT AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Chairman | |
| Glactone Pharma Development AB | Director/Board Member Chairman | ||
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder Director/Board Member | |
| ASLAN PHARMACEUTICALS LIMITED | Biotechnology | Founder Director of Finance/CFO | |
Aslan Pharmaceuticals Taiwan Ltd.
 Aslan Pharmaceuticals Taiwan Ltd. BiotechnologyHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Taiwan Ltd. develops novel medicines. The private company is based in Taipei, Taiwan and was founded in 2014. | Biotechnology | Director/Board Member Director/Board Member | |
| Nefarma | Director/Board Member Director/Board Member | ||
Gedea Biotech AB
 Gedea Biotech AB Miscellaneous Commercial ServicesCommercial Services Gedea Biotech AB provides drugs for the treatment of bacterial and fungal diseases. It develops an antibiotic-free treatment for vaginal fungal infections. The company was founded by Olov Arvid Sterner, Ingrid Helena Strevens, Ulf Christian Ellervik, and Sophie Margareta Manner and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Founder Founder | |
Trophea AB
 Trophea AB Miscellaneous Commercial ServicesCommercial Services Trophea AB provides medical need for a treatment of skin atrophy caused by long-term use of topical glucocorticoids. The company is headquartered in Helsingborg, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
InnovHeart Srl
 InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Medical Specialties | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Nina Capital SGEIC SA
 Nina Capital SGEIC SA Investment ManagersFinance Nina Capital SGEIC SA (Nina Capital) is a venture capital firm founded in 2019 by Marta Gaia Zanchi. It is headquartered in Barcelona, Spain. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Adenovir Pharma AB
 Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Chairman | |
Dansk Erhverv
 Dansk Erhverv Miscellaneous Commercial ServicesCommercial Services Dansk Erhverv is a business organization and employer association representing one of the world's most powerful business communities. The private company is based in Copenhagen, Denmark, and has subsidiaries in Denmark. With a membership of 18,000 companies and over 100 industry associations, the organization works daily to promote Denmark as the best country in the world to do business. The Danish company was founded by Tom Sten Behrens-Sørensen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Suecia | 23 |
| Dinamarca | 12 |
| Italia | 6 |
| Estados Unidos | 5 |
| Países Bajos | 4 |
Sectorial
| Health Technology | 31 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Finance | 3 |
| Electronic Technology | 2 |
Operativa
| Director/Board Member | 323 |
| Corporate Officer/Principal | 136 |
| Chairman | 76 |
| Independent Dir/Board Member | 69 |
| Chief Executive Officer | 66 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Bertil Lindmark
- Conexiones Empresas
